MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

BAX · NYSE

Baxter International Inc.

Health Care · Medical/Dental Instruments

Reference price$24.37As of Jul 28, 2026
Market capitalization$12.59B
52-week range$15.73–$29.35
S&P 500 portfolio weight0.02%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$17.00-30.2% vs. reference
Average$23.25-4.6% vs. reference
High$27.00+10.8% vs. reference
2 Buy6 Hold1 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportJul 30, 2026Jun 2026
Consensus EPS$0.367 estimates
Expected range$0.36–$0.38Low to high EPS
Dec 2026$1.91Street EPS consensus
Dec 2027$1.96Street EPS consensus
Dec 2028$2.17Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+5.7% YoY$11.24B$10.64B
Operating income($0.31B)$0.01B
Net income($0.96B)($0.65B)
Operating cash flow$0.85B$1.02B
Capital expenditures($0.51B)($0.45B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?

Zacks

Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline

NASDAQ.com

After Hours Most Active for Jul 13, 2026 : NVDA, QXO, RIG, NOK, GRAB, INTC, AAPL, BGIA, WBD, BAX, XOM, V

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.